Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,520.00
-85.00 (-1.85%)
At close: Mar 28, 2025, 3:30 PM KST
-34.01%
Market Cap 49.32B
Revenue (ttm) 73.00B
Net Income (ttm) 3.00B
Shares Out 10.91M
EPS (ttm) 278.00
PE Ratio 16.26
Forward PE n/a
Dividend 150.00 (3.32%)
Ex-Dividend Date Dec 27, 2024
Volume 18,631
Average Volume 136,450
Open 4,590.00
Previous Close 4,605.00
Day's Range 4,490.00 - 4,590.00
52-Week Range 4,095.00 - 6,950.00
Beta 0.13
RSI 26.71
Earnings Date Feb 21, 2025

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 270
Stock Exchange KOSDAQ
Ticker Symbol 014570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.